SCHEMBL3965578

SCHEMBL3965578

CCN(c1ccc(-c2ccccc2)cc1)[C@@](CC(C)C)(C(N)=O)S(C)(=O)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.40
BCL2L1 Q07817 2/20 0.36
ADAMTS4 O75173 1/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
MMP13 P45452 2/20 0.36
MMP1 P03956 1/20 0.36
MMP2 P08253 1/20 0.36
MMP3 P08254 1/20 0.36
MMP9 P14780 1/20 0.36
MMP8 P22894 1/20 0.36
MMP14 P50281 1/20 0.36
ADAM17 P78536 1/20 0.36
RORC P51449 4/20 0.35
GPR88 Q9GZN0 1/20 0.35
KDM4E B2RXH2 1/20 0.35
AGTR1 P30556 1/20 0.35
ALOX5 P09917 1/20 0.34
CNR2 P34972 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4304994 0.99 MCL1 (0.39) MCL1BCL2L1ADAMTS4ALDH1A1MAPT
SCHEMBL4957427 0.65 KMT2A (0.39) ALDH1A1MAPTKDM4E
SCHEMBL2163020 0.64 GPR88 (0.44) MCL1BCL2L1ALDH1A1MAPTHPGD
SCHEMBL2170767 0.64 MAPT (0.37) ALDH1A1MAPTKDM4E
SCHEMBL26227072 0.62 MAPT (0.37) ALDH1A1MAPTSLC6A2
SCHEMBL5132083 0.62 MMP2 (0.54) MCL1ALDH1A1MAPTMMP2MMP9
SCHEMBL5131313 0.62 MMP2 (0.54) MCL1ALDH1A1MAPTMMP2MMP9
SCHEMBL2163024 0.62 GPR88 (0.56) ALDH1A1GPR88
SCHEMBL27654625 0.60 ALDH1A1 (0.60) ALDH1A1MAPTHPGDGPR88KDM4E
SCHEMBL16933577 0.60 SMN1; SMN2 (0.51) MCL1ADAMTS4ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1706402-A4 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA LTD (CA) 2009-03-18 EP claimed
EP-1706402-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS Merck Frosst Canada Ltd. (CA) 2006-10-04 EP claimed
WO-2005066159-A1 CATHEPSIN CYSTEINE PROTEASE INHIBITORS MERCK FROSST CANADA LTD. (CA) 2005-07-21 WO claimed
US-20090176859-A1 Cathepsin cysteine protease inhibitors MERCK FROSST CANADA, LTD. (CA) 2009-07-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176859-A1 Cathepsin cysteine protease inhibitors CTSE, CTSB, CTSS MCL1 2228/4885BCL2L1 590/4885ADAMTS4 2987/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.